Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GINGER: Insulin Glulisine + Glargine vs Conventional Insulin in T2DM
NCT00174668Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2004
- Primary completion
- Nov 2007
- Modality
- Peptides
- Countries
- 15
01
Overview
A Phase 3 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Nov 2004; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00174668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174668.